Timelo Investment Management Inc. Altimmune, Inc. Transaction History
Timelo Investment Management Inc.
- $256 Million
- Q1 2024
A detailed history of Timelo Investment Management Inc. transactions in Altimmune, Inc. stock. As of the latest transaction made, Timelo Investment Management Inc. holds 294,095 shares of ALT stock, worth $2.2 Million. This represents 1.17% of its overall portfolio holdings.
Number of Shares
294,095
Previous 809,095
63.65%
Holding current value
$2.2 Million
Previous $9.1 Million
67.12%
% of portfolio
1.17%
Previous 19.65%
Shares
4 transactions
Others Institutions Holding ALT
# of Institutions
184Shares Held
44.4MCall Options Held
1.1MPut Options Held
647K-
State Street Corp Boston, MA8.65MShares$64.7 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.04MShares$30.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.13MShares$23.4 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA2.75MShares$20.6 Million3.41% of portfolio
-
Morgan Stanley New York, NY2.21MShares$16.5 Million0.0% of portfolio
About Altimmune, Inc.
- Ticker ALT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,025,300
- Market Cap $367M
- Description
- Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide (proposed INN, formerly known as ALT-801), is a GLP-1/glucagon dual receptor agonist that is in Phase 1b trial for the treatment of obesity and non-alcoholic steatohepatit...